Analystreport

Quest Diagnostics Incorporated (NYSE: DGX) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $158.00 price target on

Quest Diagnostics Incorporated  (DGX) 
Last quest diagnostics incorporated earnings: 4/22 06:45 am Check Earnings Report
US:NYSE Investor Relations: ir.questdiagnostics.com